Incentives for Influenza Vaccination

NCT ID: NCT06300242

Last Updated: 2024-05-13

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

69972 participants

Study Classification

INTERVENTIONAL

Study Start Date

2024-01-17

Study Completion Date

2024-02-29

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

In this work, we are assessing the impact of messaging with or without a $50 financial incentive on influenza vaccination rates in a county health system. Our main hypothesis is that a message with a $50 financial incentive will increase vaccination rates relative to a control/"treatment as usual" group. We further hypothesize that the financial incentive will increase vaccination rates relative to the message only arm.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Influenza Vaccination

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

HEALTH_SERVICES_RESEARCH

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Message Only

Patients sent an email or SMS reminding them to get vaccinated against the flu.

Group Type EXPERIMENTAL

Reminders

Intervention Type BEHAVIORAL

Reminders

Message + Financial Incentive

Patients sent an email or SMS reminding them to get vaccinated against the flu and offering them a $50 financial incentive if they are vaccinated within 1-week.

Group Type EXPERIMENTAL

Reminders

Intervention Type BEHAVIORAL

Reminders

Financial Incentive

Intervention Type BEHAVIORAL

$50 financial incentive for getting vaccinated within 1-week

Active Control

Patients not sent any reminder message.

Group Type ACTIVE_COMPARATOR

Placebo

Intervention Type OTHER

No special messages or incentives

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Reminders

Reminders

Intervention Type BEHAVIORAL

Financial Incentive

$50 financial incentive for getting vaccinated within 1-week

Intervention Type BEHAVIORAL

Placebo

No special messages or incentives

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Ages 18 and over
* Empaneled patients or non-empaneled patients with a primary care visit in past 18 months with valid insurance
* Due for an annual flu shot according to the electronic medical record
* Active phone number or email
* Do not have "Do not contact" flag

Exclusion Criteria

* Under age 18
* Received an annual flu shot based on medical record
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

J-PAL North America

UNKNOWN

Sponsor Role collaborator

University of Southern California

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Mireille Jacobson

Associate Professor

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Contra Costa Health Services

Martinez, California, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

UP-23-00859

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

SAVE: School Ambassadors for Vaccine Education
NCT07164144 NOT_YET_RECRUITING NA
Influenza Reminder Text-Messaging
NCT06587984 COMPLETED NA
Body and Social Behavior
NCT05654441 COMPLETED PHASE4